CD14 C-260T gene polymorphism and ischemic heart disease susceptibility: A HuGE review and meta-analysis

Genetics in Medicine

Volumn 11, Issue 6, 2009, Pages 403-408

  Zhang, Hai Feng ^a   Zhong, Bao Liang ^b   Zhu, Wa Li ^a   Xie, Shuang Lun ^c   Qiu, Li Xin ^d   Zhu, Li Guang ^a   Wang, Yan ^a   Lei, Lei ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

CD14; Ischemic heart disease; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

ACUTE CORONARY SYNDROME; CORONARY ARTERY OBSTRUCTION; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; REVIEW; STABLE ANGINA PECTORIS;

ANTIGENS, CD14; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; JAPAN; MYOCARDIAL ISCHEMIA; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

ANGINA;

EID: 69549126677     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181a16cb0     Document Type: Review

References (57)

1. Chen Y, Rollins J, Paigen B, Wang X. Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab 2007;6:164-179. (Pubitemid 47324136)
2. Hawe E, Talmud PJ, Miller GJ, Humphries SE. Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study. Ann Hum Genet 2003;67:97-106. (Pubitemid 38312817)
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
4. Becker AE, de Boer OJ, van Der Wal AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med 2001;52:289-297. (Pubitemid 32195326)
5. Muhlestein JB, Anderson JL. Chronic infection and coronary artery disease. Cardiol Clin 2003;21:333-362.
6. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
7. Hubacek JA, Rothe G, Pit'ha J, et al. C(-260)3T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999;99:3218-3220. [Erratum, Circulation 1999;100:2550.]
8. Goyert S, Ferrero E, Rettig W, Yenamandra A, Obata F, Le Beau M. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988;239:497-500. (Pubitemid 18084313)
9. Fernandez-Real JM, Broch M, Richart C, Vendrell J, Lopez-Bermejo A, Ricart W. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1780-1784. (Pubitemid 36623404)
10. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999;20:976-983. (Pubitemid 129540855)
11. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001;167:5838-5844.
12. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146. (Pubitemid 43754289)
13. Little J, Higgins JPT, editors. The HuGENet™ HuGE review handbook, version 1.0. Available at: http://www.hugenet.org.uk. Accessed December 2, 2008.
14. Mottl AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 2008;10:560-574.
15. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004;36:1312-1318. (Pubitemid 39577941)
16. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003;107:531-537. (Pubitemid 36176800)
17. Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 2004;109:1359-1365.
18. Richards M, Nicholls MG, Espiner EA, et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 2006;47:52-60. (Pubitemid 43005164)
19. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ. A navigator for human genome epidemiology. Nat Genet 2008;40:124-125.
20. 2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005;162:201-211.
21. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005;24:1291-1306. (Pubitemid 40585169)
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
23. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309:1351-1355.
24. Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med 1997;16:2741-2758. (Pubitemid 27496919)
25. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999;18:2693-2708.
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634. (Pubitemid 27387172)
27. Shimada K, Watanabe Y, Mokuno H, Iwama Y, Daida H, Yamaguchi H. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 2000;86:682-684. (Pubitemid 30687431)
28. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 2004;90:847-852. (Pubitemid 39022574)
29. Schoenhagen P, Tuzcu EM, Ellis SG. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process. Circulation 2002;106:760-762.
30. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999;19:932-938. (Pubitemid 29177340)
31. Zee RY, Lindpaintner K, Struk B, Hennekens CH, Ridker PM. A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 2001;154:699-702. (Pubitemid 32232168)
32. Koch W, Kastrati A, Mehilli J, von Beckerath N, Schomig A. CD14 gene-159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am Heart J 2002;143:971-976. (Pubitemid 34666886)
33. Koenig W, Khuseyinova N, Hoffmann MM, et al. CD14 C(-260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 2002;40:34-42. (Pubitemid 34701374)
34. Nauck M, Winkelmann BR, Hoffmann MM, Bohm BO, Wieland H, Marz W. C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. J Am Coll Cardiol 2002;90:1249-1252.
35. Hohda S, Kimura A, Sasaoka T, et al. Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 2003;44:613-622. (Pubitemid 41518962)
36. Longobardo MT, Cefalu AB, Pezzino F, et al. The C(-260)3T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 2003;3:161-165. (Pubitemid 37491546)
37. Pan M, Gu DF, Chen F, et al. C(-260)T polymorphism in CD14 gene promoter and its association with coronary heart disease in Chinese population. Chin J Misdiagnosis 2003;3:1458-1459.
38. Morange PE, Tiret L, Saut N, et al. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME Study. Eur J Hum Genet 2004;12:1041-1049. (Pubitemid 39600131)
39. Arroyo-Espliguero R, El-Sharnouby K, Vazquez-Rey E, Kalidas K, Jeffery S, Kaski JC. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 2005;98:307-312. (Pubitemid 40431179)
40. Li Y, Xiong XQ, Zhang PA, Ming KH. Association of C-159T polymorphism in promoter region of CD14 and coronary heart disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005;22:687-690.
41. Morange PE, Saut N, Alessi MC, et al. Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis 2005;179:317-323. (Pubitemid 40364626)
42. Hu R, Cheng LX, He MA, Wu TC. The polymorphism in the promoter of the CD14 monocyte receptor gene is a risk factor for coronary heart disease in Wuhan population. Chin J Gen Geriatr Heart Brain Vessel Dis 2006;8:184-186.
43. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 2009;27:88-94.
44. Li L, Zhang K, Qiu F, et al. Association of C (-159)T polymorphism in the promoter of CD14 gene with coronary heart disease in Han population of Jiangsu province. J Clin Rehabil Tissue Eng Res 2007;11:8749-8752. (Pubitemid 350081266)
45. Lorenzova A, Stanek V, Gebauerova M, et al. High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes. Clin Chem Lab Med 2007;45:855-861. (Pubitemid 47041899)
46. Xie RX, Bu-Ai JE, Ma YT, Ma X, Fu ZY, Jia ZH. The polymorphism in the promoter of CD14 gene and its association with coronary heart disease and blood lipid levels in Chinese Han and Uighur population. Chin J Cardiovasc Rev 2008;6:403-406.
47. Wei YS, Liu YG, Tang RG, et al. Association between the polymorphism of the CD14 gene promoter and coronary heart disease. J Fourth Mil Med Univ 2006;27:630-633.
48. Multinational monitoring of trends and determinants in cardiovascular diseases: "MONICA Project." Manual of operations WHO/MNC 82.2. 1983.
49. McAteer JB, Prudente S, Bacci S, et al. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. Diabetes 2008;57:1125-1130.
50. Pan Z, Trikalinos TA, Kavvoura FK, Lau J, Ioannidis JP. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Med 2005;2:e334. (Pubitemid 43020990)
51. Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis. Prevention, assessment and adjustments. Sussex: Wiley, 2005.
52. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 2000;53:207-216. (Pubitemid 30151226)
53. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-1129.
54. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001;323:101-105. (Pubitemid 32681979)
55. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006;295:676-680. (Pubitemid 43209069)
56. Watkins H, Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 2006;7:163-173. (Pubitemid 43361528)
57. Pavia M, Pileggi C, Nobile CG, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr 2006;83:1126-1134. (Pubitemid 44713114)